REGN logo

REGN Income Tax

Annual Income Tax

$367.30 M
+$121.60 M+49.49%

December 31, 2024

Summary

Performance

1-Year Change

+49.49%

3-Year Change

-70.63%

5-Year Change

+17.24%

15-Year Change

-58.26%

REGN Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.29%
REGN annual income tax is higher than 96.29% of companies in Healthcare sector

High & Low

All-time High

$1.25 B
REGN annual income tax is currently -70.63% below its historical high of $1.25 billion

3-Year Low

$245.70 M
REGN annual income tax is currently +49.49% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
REGN previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
REGN next annual earnings announcement has not yet been scheduled

OtherREGNexpensesmetrics:

Annual Total Expenses

$10.11 B
REGN annual total expenses is $10.11 billion

Annual Operating Expenses

$8.14 B
REGN annual total operating expenses is $8.14 billion

Annual Cost Of Goods Sold

$1.97 B
REGN annual cost of goods sold is $1.97 billion

Annual Interest Expense

$55.20 M
REGN annual interest expense is $55.20 million

Quarterly Income Tax

$40.40 M
-$112.00 M-73.49%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+436.67%

3-Year Change

+436.67%

5-Year Change

+436.67%

REGN Quarterly Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

92.08%
REGN quarterly income tax is higher than 92.08% of companies in Healthcare sector

High & Low

All-time High

$653.90 M
REGN quarterly income tax is currently -93.82% below its historical high of $653.90 million

3-Year Low

-$21.30 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
REGN previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
REGN next earnings announcement is scheduled for May 2, 2025

OtherREGNexpensesmetrics:

Quarterly Total Expenses

$2.79 B
REGN quarterly total expenses is $2.79 billion

Quarterly Operating Expenses

$2.22 B
REGN quarterly total operating expenses is $2.22 billion

Quarterly Cost Of Goods Sold

$565.40 M
REGN quarterly cost of goods sold is $565.40 million

Quarterly Interest Expense

$10.50 M
REGN quarterly interest expense is $10.50 million

TTM Income Tax

$367.30 M
+$52.40 M+16.64%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+49.49%

3-Year Change

+49.49%

5-Year Change

+49.49%

REGN TTM Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

95.38%
REGN TTM income tax is higher than 95.38% of companies in Healthcare sector

High & Low

All-time High

$1.25 B
REGN TTM income tax is currently -70.63% below its historical high of $1.25 billion

3-Year Low

$184.20 M
REGN TTM income tax is currently +99.40% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
REGN previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
REGN next earnings announcement is scheduled for May 2, 2025

OtherREGNexpensesmetrics:

Annual Total Expenses

$10.11 B
REGN annual total expenses is $10.11 billion

Annual Operating Expenses

$8.14 B
REGN annual total operating expenses is $8.14 billion

TTM Cost Of Goods Sold

$1.97 B
REGN TTM cost of goods sold is $1.97 billion

TTM Interest Expense

$55.20 M
REGN TTM interest expense is $55.20 million

Income Tax Formula

Income Tax Expense = Current Tax Expense + Deferred Tax Expense

REGN Income Tax Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+49.5%+436.7%+49.5%
3 y3 years-70.6%+436.7%+49.5%
5 y5 years+17.2%+436.7%+49.5%

REGN Income Tax Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-70.6%+49.5%-85.3%+289.7%-70.6%+99.4%
5 y5-year-70.6%+49.5%-93.8%+289.7%-70.6%+99.4%
alltimeall time-70.6%+209.4%-93.8%+112.0%-70.6%+209.4%

Regeneron Pharmaceuticals Income Tax History

DateAnnualQuarterlyTTM
Dec 2024
$367.30 M(+49.5%)
$40.40 M(-73.5%)
$367.30 M(+16.6%)
Sep 2024
-
$152.40 M(-22.2%)
$314.90 M(+18.6%)
Jun 2024
-
$195.80 M(-1019.2%)
$265.50 M(+44.1%)
Mar 2024
-
-$21.30 M(+77.5%)
$184.20 M(-25.0%)
Dec 2023
$245.70 M(-52.8%)
-$12.00 M(-111.7%)
$245.70 M(-36.2%)
Sep 2023
-
$103.00 M(-10.0%)
$385.30 M(-19.1%)
Jun 2023
-
$114.50 M(+184.8%)
$476.40 M(+0.7%)
Mar 2023
-
$40.20 M(-68.5%)
$473.00 M(-9.1%)
Dec 2022
$520.40 M(-58.4%)
$127.60 M(-34.3%)
$520.40 M(-22.0%)
Sep 2022
-
$194.10 M(+74.7%)
$667.20 M(+1.5%)
Jun 2022
-
$111.10 M(+26.8%)
$657.50 M(-45.2%)
Mar 2022
-
$87.60 M(-68.1%)
$1.20 B(-4.0%)
Dec 2021
$1.25 B(+320.8%)
$274.40 M(+48.8%)
$1.25 B(+18.9%)
Sep 2021
-
$184.40 M(-71.8%)
$1.05 B(+2.8%)
Jun 2021
-
$653.90 M(+374.5%)
$1.02 B(+161.7%)
Mar 2021
-
$137.80 M(+82.8%)
$391.00 M(+31.6%)
Dec 2020
$297.20 M(-5.1%)
$75.40 M(-51.7%)
$297.20 M(-7.0%)
Sep 2020
-
$156.20 M(+623.1%)
$319.60 M(+21.8%)
Jun 2020
-
$21.60 M(-50.9%)
$262.30 M(-3.7%)
Mar 2020
-
$44.00 M(-55.0%)
$272.30 M(-13.1%)
Dec 2019
$313.30 M(+187.2%)
$97.80 M(-1.1%)
$313.30 M(+339.4%)
Sep 2019
-
$98.90 M(+213.0%)
$71.30 M(+424.3%)
Jun 2019
-
$31.60 M(-62.8%)
$13.60 M(-84.3%)
Mar 2019
-
$85.00 M(-158.9%)
$86.70 M(-20.5%)
Dec 2018
$109.10 M(-87.6%)
-$144.20 M(-450.0%)
$109.10 M(-82.8%)
Sep 2018
-
$41.20 M(-60.6%)
$634.55 M(-17.7%)
Jun 2018
-
$104.70 M(-2.5%)
$770.64 M(-4.2%)
Mar 2018
-
$107.40 M(-71.8%)
$804.04 M(-8.6%)
Dec 2017
$880.00 M(+102.6%)
$381.25 M(+115.0%)
$880.00 M(+49.9%)
Sep 2017
-
$177.29 M(+28.4%)
$587.17 M(+14.9%)
Jun 2017
-
$138.11 M(-24.7%)
$510.96 M(+9.0%)
Mar 2017
-
$183.36 M(+107.4%)
$468.89 M(+8.0%)
DateAnnualQuarterlyTTM
Dec 2016
$434.30 M(-26.3%)
$88.42 M(-12.5%)
$434.30 M(+3.9%)
Sep 2016
-
$101.08 M(+5.2%)
$418.18 M(-16.4%)
Jun 2016
-
$96.04 M(-35.4%)
$499.99 M(-6.9%)
Mar 2016
-
$148.77 M(+105.8%)
$537.30 M(-8.8%)
Dec 2015
$589.04 M(+39.2%)
$72.30 M(-60.5%)
$589.04 M(-4.4%)
Sep 2015
-
$182.89 M(+37.1%)
$616.37 M(+15.9%)
Jun 2015
-
$133.35 M(-33.5%)
$531.93 M(+4.1%)
Mar 2015
-
$200.50 M(+101.3%)
$511.03 M(+20.8%)
Dec 2014
$423.11 M(+49.7%)
$99.63 M(+1.2%)
$423.11 M(+1.1%)
Sep 2014
-
$98.45 M(-12.5%)
$418.47 M(+3.5%)
Jun 2014
-
$112.45 M(-0.1%)
$404.40 M(+14.8%)
Mar 2014
-
$112.58 M(+18.5%)
$352.27 M(+24.6%)
Dec 2013
$282.64 M(-184.2%)
$94.99 M(+12.6%)
$282.64 M(-290.7%)
Sep 2013
-
$84.38 M(+39.9%)
-$148.20 M(-36.3%)
Jun 2013
-
$60.32 M(+40.4%)
-$232.57 M(-20.6%)
Mar 2013
-
$42.96 M(-112.8%)
-$292.89 M(-12.8%)
Dec 2012
-$335.85 M(>+9900.0%)
-$335.85 M(<-9900.0%)
-$335.85 M(>+9900.0%)
Sep 2012
-
$0.00(0.0%)
-$615.00 K(+1060.4%)
Jun 2012
-
$0.00(-100.0%)
-$53.00 K(-95.3%)
Dec 2011
-$1.13 M(<-9900.0%)
-$615.00 K(-209.4%)
-$1.13 M(+119.0%)
Sep 2011
-
$562.00 K(-165.1%)
-$517.00 K(-52.1%)
Jun 2011
-
-$863.00 K(+299.5%)
-$1.08 M(+399.5%)
Mar 2011
-
-$216.00 K(<-9900.0%)
-$216.00 K(<-9900.0%)
Dec 2010
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2010
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2010
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2010
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2009
-$4.12 M(-275.3%)
-
-
Mar 2009
-
$0.00(-100.0%)
$2.35 M(0.0%)
Dec 2008
$2.35 M(>+9900.0%)
-$728.00 K(-123.6%)
$2.35 M(-23.6%)
Sep 2008
-
$3.08 M
$3.08 M
Dec 2007
$0.00
-
-

FAQ

  • What is Regeneron Pharmaceuticals annual income tax?
  • What is the all time high annual income tax for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual income tax year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly income tax?
  • What is the all time high quarterly income tax for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly income tax year-on-year change?
  • What is Regeneron Pharmaceuticals TTM income tax?
  • What is the all time high TTM income tax for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals TTM income tax year-on-year change?

What is Regeneron Pharmaceuticals annual income tax?

The current annual income tax of REGN is $367.30 M

What is the all time high annual income tax for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual income tax is $1.25 B

What is Regeneron Pharmaceuticals annual income tax year-on-year change?

Over the past year, REGN annual income tax has changed by +$121.60 M (+49.49%)

What is Regeneron Pharmaceuticals quarterly income tax?

The current quarterly income tax of REGN is $40.40 M

What is the all time high quarterly income tax for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly income tax is $653.90 M

What is Regeneron Pharmaceuticals quarterly income tax year-on-year change?

Over the past year, REGN quarterly income tax has changed by +$52.40 M (+436.67%)

What is Regeneron Pharmaceuticals TTM income tax?

The current TTM income tax of REGN is $367.30 M

What is the all time high TTM income tax for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high TTM income tax is $1.25 B

What is Regeneron Pharmaceuticals TTM income tax year-on-year change?

Over the past year, REGN TTM income tax has changed by +$121.60 M (+49.49%)